NCT04359823View on ClinicalTrials.gov

DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

April 23, 2021

Study Completion Date

April 23, 2021

Conditions
Actinic Porokeratosis
Interventions
DRUG

Lovastatin 2%, 2% Cholesterol Cream

Patients selected to the study will be randomly assigned to this arm. They will have a 50% chance of being placed in this arm compared to the other arm.

DRUG

Lovastatin 2% Cream

Patients selected to the study will be randomly assigned to this arm. They will have a 50% chance of being placed in this arm compared to the other arm.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT04359823 - DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone | Biotech Hunter | Biotech Hunter